Vera Bril

Mount Sinai Hospital
Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 308 publications

Efficacy and Safety of Vemircopan in Generalized Myasthenia Gravis: A Randomized Clinical Trial.

Efficacy and Safety of Vemircopan in Generalized Myasthenia Gravis: A Randomized Clinical Trial.

Journal: JAMA neurology

Published: April 27, 2026

The Muscle Cramp Impact Index: A Patient-Centered Scale for the Assessment of Muscle Cramps.

The Muscle Cramp Impact Index: A Patient-Centered Scale for the Assessment of Muscle Cramps.

Journal: Neurology

Published: April 09, 2026

Nipocalimab and other FcRn blockers in neuromuscular disorders.

Nipocalimab and other FcRn blockers in neuromuscular disorders.

Journal: Pharmacology & therapeutics

Published: March 03, 2026

Long-term use of rozanolixizumab in generalised myasthenia gravis: final pooled analysis of the phase III MycarinG study and two open-label extensions.

Long-term use of rozanolixizumab in generalised myasthenia gravis: final pooled analysis of the phase III MycarinG study and two open-label extensions.

Journal: Therapeutic advances in neurological disorders

Published: December 24, 2025

Overall Diagnostic Performance of Multiple Versus Single Physical Examination Tests for the Prediction of Future Diabetic Neuropathy Risk.

Overall Diagnostic Performance of Multiple Versus Single Physical Examination Tests for the Prediction of Future Diabetic Neuropathy Risk.

Journal: Journal of the peripheral nervous system : JPNS

Published: October 31, 2025

The Effect of Thymectomy on the Incidence of Extrathymic Cancers and Autoimmune Diseases in Patients With Non-Thymomatous Myasthenia Gravis.

The Effect of Thymectomy on the Incidence of Extrathymic Cancers and Autoimmune Diseases in Patients With Non-Thymomatous Myasthenia Gravis.

Journal: Muscle & nerve

Published: October 23, 2025

Rescue therapy in myasthenia gravis.

Rescue therapy in myasthenia gravis.

Journal: International review of neurobiology

Published: October 16, 2025

Quality of Life in Patients with Chronic Inflammatory Demyelinating Neuropathies Treated with Subcutaneous Immunoglobulin.

Quality of Life in Patients with Chronic Inflammatory Demyelinating Neuropathies Treated with Subcutaneous Immunoglobulin.

Journal: The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques

Published: September 02, 2025

Treatment Preferences of Patients With Myasthenia Gravis: A Qualitative Study.

Treatment Preferences of Patients With Myasthenia Gravis: A Qualitative Study.

Journal: Muscle & nerve

Published: July 24, 2025

Self-administration of rozanolixizumab via manual push and infusion pump methods in patients with generalised myasthenia gravis: a randomised, phase 3, open-label, crossover study.

Self-administration of rozanolixizumab via manual push and infusion pump methods in patients with generalised myasthenia gravis: a randomised, phase 3, open-label, crossover study.

Journal: Journal of neurology

Published: July 23, 2025

Measuring the effect of rozanolixizumab using the Myasthenia Gravis Impairment Index: analyses from the randomized phase 3 MycarinG study.

Measuring the effect of rozanolixizumab using the Myasthenia Gravis Impairment Index: analyses from the randomized phase 3 MycarinG study.

Journal: Journal of neurology

Published: July 22, 2025

Author Response: Effect of Immunosuppression in Risk of Developing Generalized Symptoms in Ocular Myasthenia Gravis: A Retrospective Cohort Study.

Author Response: Effect of Immunosuppression in Risk of Developing Generalized Symptoms in Ocular Myasthenia Gravis: A Retrospective Cohort Study.

Journal: Neurology

Published: July 18, 2025

Showing 1-12 of 308

Last Updated: 09/26/2026